EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Human herpesvirus‐associated transposable element activation in human aging brains with Alzheimer's disease

Yayan Feng, Shu-Qin Cao, Yi Shi, Anna Sun, Margaret E Flanagan, James B Leverenz, Andrew A Pieper, Jae U Jung, Jeffrey Cummings, Evandro Fei Fang, Pengyue Zhang, Feixiong Cheng

Alzheimer's & Dementia · 2025

DOI: 10.1002/alz.14595 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alzheimer's & Dementia, 2025. Verfasst von Yayan Feng und 11 weiteren Autor:innen. Beteiligte Einrichtung: Cleveland Clinic Genome Center, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, USA. Hauptthemen laut MEDLINE: Alzheimer Disease, Brain, Aging, DNA Transposable Elements. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIA NIH HHS, NINDS NIH HHS, Akershus University Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION Human herpesvirus (HHV) has been linked to Alzheimer's disease (AD), but the underlying mechanisms remain unknown. METHODS We leveraged functional genomics data from Religious Orders Study or the Rush Memory and Aging Project (ROS/MAP) and Mount Sinai Brain Bank (MSBB) brain biobanks and single‐cell RNA‐sequencing data from HHV‐infected forebrain organoids to investigate HHV‐infection‐associated transposable element (TE) dysregulation underlying AD etiologies. RESULTS We identified widespread TE dysregulation in HHV‐positive human AD brains, including an astrocyte‐specific upregulation of LINE1 subfamily TEs in HHV‐positive human AD brains. We further pinpointed astrocyte‐specific LINE1 upregulation that could potentially regulate target gene NEAT1 expression via long‐range enhancer‐promoter chromatin interactions. This LINE1 dysregulation can be partially reversed by the usage of anti‐HHV drugs (valacyclovir and acyclovir) in a virus‐infected human brain organoid model. Finally, we demonstrated that valacyclovir rescued tau‐associated neuropathology and alleviated LINE1 activation in an experimental tau aggregation model. DISCUSSION Our analysis provides associations linking molecular, clinical, and neuropathological AD features with HHV infection, which warrants future clinical validation. Highlights Via analysis of bulk RNA‐seq data in two large‐scale human brain biobanks, ROS/MAP ( n = 109 pathologically confirmed AD and n = 44 cognitively healthy controls) and MSBB ( n = 284 AD and n = 150 cognitively healthy controls), we identified widespread TE activation in HHV‐positive human AD brains and significantly positive associations of HHV RNA abundance with APOE4 genotype, Braak staging score, and CERAD score. We identified cell type‐specific LINE1 upregulation in both microglia and astrocytes of human AD brains via long‐range enhancer–promoter chromatin interactions on lncRNA nuclear enriched abundant transcript 1 ( NEAT1 ). We determined that usage of valacyclovir and acyclovir was significantly associated with reduced incidence of AD in a large real‐world patient database. Using the HEK293 tau P301S model and U2OS mt‐Keima cell model, we determined that valacyclovir treatment rescued tau‐associated neuropathology and alleviated activation of LINE1 with increased cellular autophagy‐level mechanistically supported clinical benefits of valacyclovir in real‐world patient data.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseBrainAgingDNA Transposable ElementsHerpesviridae InfectionsHumansMaleLong Interspersed Nucleotide ElementsFemaleAgedAstrocytes

Stichwörter der Autor:innen

Alzheimer's disease (AD)human herpesvirus (HHV)long interspersed nuclear element 2 (LINE1)neuroinflammationtransposable element (TE)valacyclovir

Substanzen

DNA Transposable Elements

Autor:innen und Institutionen

  • Cleveland Clinic Genome Center, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, USA.
  • Genomic Medicine Institute, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, USA.
  • Department of Clinical Molecular Biology, University of Oslo and Akershus University Hospital, Lørenskog, Norway.
  • Department of Biostatistics and Health Data Science, Indiana University, Indianapolis, Indiana, USA.
  • Department of Pathology, Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases, University of Texas Health San Antonio, San Antonio, Texas, USA.
  • Department of Molecular Medicine, Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, Cleveland, Ohio, USA.

Förderung

  • NIA NIH HHS
  • NINDS NIH HHS
  • Akershus University Hospital
  • NIGMS NIH HHS
  • Research Council of Norway
  • Cure Alzheimer's Fund
  • Rosa sløyfe/Norwegian Cancer Society & Norwegian Breast Cancer Society
  • Molecule AG/VITADAO

Zitieren

APA

Feng, Y., Cao, S. Q., Shi, Y., Sun, A., Flanagan, M. E., Leverenz, J. B., Pieper, A. A., Jung, J. U., Cummings, J., Fang, E. F., Zhang, P., & Cheng, F. (2025). Human herpesvirus‐associated transposable element activation in human aging brains with Alzheimer's disease. Alzheimer's & Dementia. https://doi.org/10.1002/alz.14595

Vancouver

Feng Y, Cao SQ, Shi Y, Sun A, Flanagan ME, Leverenz JB, et al. Human herpesvirus‐associated transposable element activation in human aging brains with Alzheimer's disease. Alzheimer's & Dementia. 2025. doi:10.1002/alz.14595

BibTeX
@article{Feng2025,
  author = {Feng, Yayan and Cao, Shu-Qin and Shi, Yi and Sun, Anna and Flanagan, Margaret E and Leverenz, James B and Pieper, Andrew A and Jung, Jae U and Cummings, Jeffrey and Fang, Evandro Fei and Zhang, Pengyue and Cheng, Feixiong},
  title = {Human herpesvirus‐associated transposable element activation in human aging brains with Alzheimer's disease},
  journal = {Alzheimer's & Dementia},
  year = {2025},
  doi = {10.1002/alz.14595}
}
Kostenlos starten →